Description
PLx Pharma Inc. is a commercial-stage drug delivery platform technology company, which is focused on its clinically validated and patent-protected PLxGuard technology.
The Company has two commercialized products, VAZALORE 81 milligram (mg) and VAZALORE 325 mg, which are liquid-filled aspirin capsules for over the counter (OTC) distribution. The Company markets VAZALORE to the healthcare professional and the consumer through several sales and marketing channels. Its product pipeline also includes other oral NSAIDs using the PLxGuard drug delivery platform, including PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, for pain and inflammation in Phase I clinical stage.
PLxGuard drug delivery platform employs a pH-dependent release mechanism that relies on association of lipidic excipients with APIs for targeted release in the GI tract.
History
PLx Pharma company was founded on a collective realization that some of the world’s most well-known and broadly used drugs—like aspirin and other NSAIDs—do so much good for people but may have GI side effects.
